Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
|
|
- Annabelle Rodgers
- 5 years ago
- Views:
Transcription
1 Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein cholesterol (LDL-C); C: triglycerides (TG); D: high-density lipoprotein cholesterol (HDL-C). *P<0.05; ***P<0.001, Student's t-test. ns: not significant.
2 Figure S2. Comparison of fasting plasma lipoprotein levels between different age groups of study participants (G1: 14 22, G2: 23 31, G3: 32 40, G4:41 49, G5: 50 58, and G5: 59 years). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein cholesterol (LDL-C); C: triglycerides (TG), D: high-density lipoprotein cholesterol (HDL-C). **P<0.01; ***P<0.001, Student's t-test. ns: not significant.
3 Figure S3. Age trends of medians in study population for A, TC (total cholesterol); LDL-C (low-density lipoprotein cholesterol); HDL-C (high-density lipoprotein cholesterol), and B, TG (triglycerides) in males and females.
4 Figure S4. Comparison of fasting plasma lipoprotein levels between urban and rural groups. Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein cholesterol (LDL-C); C: triglycerides (TG); D: high-density lipoprotein cholesterol (HDL-C). ns: not significant (P>0.05, Student's t-test).
5 Figure S5. Distribution of fasting plasma lipoprotein levels between white-collar and bluecollar groups of study population. Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein cholesterol (LDL-C); C: triglycerides (TG); D: highdensity lipoprotein cholesterol (HDL-C). ns: not significant (P>0.05, Student's t-test).
6 Figure S6. Comparison of fasting plasma lipoprotein levels between urban white-collar and urban blue-collar sub-groups of participants. Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein cholesterol (LDL-C); C: triglycerides (TG); D: high-density lipoprotein cholesterol (HDL-C). ns: not significant (P>0.05, Student's t-test).
7 Figure S7. Comparison of fasting plasma lipoprotein levels between smokers and nonsmokers sub-groups of study population. Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein cholesterol (LDL-C); C: triglycerides (TG); D: high-density lipoprotein cholesterol (HDL-C). P>0.05, Student's t-test. ns: not significant.
8 Figure S8. Effect of smoking status on stratification of the study population into plasma lipoprotein-based CHD-risk categories. Statistical significance was determined by z-test for two population proportions. (P>0.05).
9 Table S1. Clinical and metabolic characteristics of the study population. Parameter Mean ± SD Range Age (years) ± Weight (kg) ± Height (cm) ± BMI (kg/m 2 ) ± BMR (cal/day) ± Body Fat (%) ± Total body fat mass (kg) ± Waist circumference (cm) ± Wrist (cm) ± Waist-to-hip ratio 0.87 ± Waist-to-height ratio 0.52 ± Systolic BP (mmhg) ± Diastolic BP (mmhg) ± Fasting glucose (mg/dl) n= ± TC (mg/dl) ± LDL-C (mg/dl) ± HDL-C (mg/dl) ± VLDL-C (mg/dl) ± TG (mg/dl) ± Non-HDL-C (mg/dl) ± TC/HDL-C 4.26 ± TG/HDL-C 3.75 ± LDL/HDL-C 2.62 ± Non-HDL/HDL-C 3.26 ± Male:Female ratio 54:65 Smokers (%) 12.6 Data are reported as means±sd except for smokers' percentage and male:female ratio. TC: total cholesterol; TG: triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: highdensity lipoprotein cholesterol; BMI: body mass index; BMR: basal metabolic rate; BP: blood pressure.
10 Table S2. Clinical and metabolic characteristics of the male participants. Parameter Mean ± SD Range Age (years) ± Weight (kg) ± Height (cm) ± BMI, kg/m ± BMR (cal/day) ± Body fat (%) ± Total body fat mass (kg) ± Waist circumference (cm) ± Wrist (cm) ± Waist-to-hip ratio 0.92 ± Waist-to-height ratio 0.53 ± Systolic BP (mmhg) ± Diastolic BP (mmhg) ± Fasting glucose (mg/dl) n= ± TC (mg/dl) ± LDL-C (mg/dl) ± HDL-C (mg/dl) ± VLDL-C (mg/dl) ± TG (mg/dl) ± Non-HDL-C (mg/dl) ± TC/HDL-C 4.46 ± TG/HDL-C 4.56 ± LDL/HDL-C 2.72 ± Non-HDL/HDL-C 3.46 ± Smokers (%) Data are reported as means±sd except smokers' percentage. TC: total cholesterol; TG: triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; BMI: body mass index; BMR: basal metabolic rate; BP: blood pressure.
11 Table S3. Clinical and metabolic characteristics of the female participants. Parameter Mean ± SD Range Age (years) ± Weight (kg) ± Height (cm) ± BMI, kg/m ± BMR (cal/day) ± Body fat (%) ± Total body fat mass (kg) ± Waist circumference (cm) ± Wrist (cm) ± Waist-to-hip ratio 0.82 ± Waist-to-height ratio 0.51 ± Systolic BP (mmhg) ± Diastolic BP (mmhg) ± Fasting glucose (mg/dl) n= ± TC (mg/dl) ± LDL-C (mg/dl) ± HDL-C (mg/dl) ± VLDL-C (mg/dl) ± TG (mg/dl) ± Non-HDL-C (mg/dl) ± TC/HDL-C 4.09 ± TG/HDL-C 3.07 ± LDL/HDL-C 2.53 ± Non-HDL/HDL-C 3.09 ± Smokers (%) 0 Data are reported as means±sd except smokers' percentage. TC: total cholesterol; TG: triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; BMI: body mass index; BMR: basal metabolic rate; BP: blood pressure.
12 Table S4. Classification of the study population into different occupational classes. Occupational Groups No. of Participants White collar Managers 4 Professionals 5 Technicians and associate professionals 7 Clerical support workers 6 Service and sales workers 2 Students* 196 Blue collar Skilled agricultural, forestry and fishery workers 36 Craft and related trades workers 8 Plant and machine operators, and Assemblers 10 Elementary occupations 15 Armed forces occupations 4 *Students were classified as white-collar participants. Table S5. Effect of gender on stratification of the study population into plasma lipoproteinbased coronary heart disease (CHD) risk-categories. Plasma lipoprotein Plasma lipoprotein CHD risk category Population % (n) P value Males (n=108) Females (n=130) Cholesterol Desirable (86) (103) Borderline high (14) (15) High 7.41 (8) 9.23 (12) LDL-C Optimal (66) (76) Near optimal/above optimal (18) (24) Borderline high 14.8 (16) (17) High 4.63 (5) 3.08 (4) Very High 2.8 (3) 6.92 (9) HDL-C Low (51) (43) * Average (42) (66) High (15) (21) TG Normal (59) (103) 0.0* Borderline high (21) (16) High 25 (27) 7.69 (10) * Very High 0.93 (1) 0.77 (1) Data are reported as percent (n). *P<0.05, z-test for 2 population proportions. LDL-C: lowdensity lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides.
13 Table S6. Effect of age on stratification of the study population into plasma lipoprotein-based coronary heart disease (CHD) risk-categories. Plasma Plasma lipoprotein Population % (n) lipoprotein CHD risk category G1 (n=71) G2 (n=47) G3 (n=29) G4 (n=39) G5 (n=26) G6 (n=26) Cholesterol Desirable (62) (39) (20) (27) (19) (22) Borderline high 4.22 (3) (5) (4) (9) (5) (3) High 8.45 (6) 6.39 (3) (5) 7.69 (3) 7.69 (2) 3.85 (1) LDL- C Optimal (49) (34)* (9) (20) 42.31(11)* (19) Near optimal/above 16.9 (12) 8.51 (4) (7) (8) (9)* (3) optimal Borderline high 4.23 (3) (5)* 31.03(9) (8) (4) (3) High 4.22 (3) 4.25 (2) 3.45 (1) 5.13 (2) 0 (0) 3.85 (1) Very High 5.63 (4) 4.25 (2) (3) 2.56 (1) 7.69 (2) 0 (0) HDL- C Low (26) (14)* (16) (17) (11) (9) Average (35) (20) (8)* (21) (10) (15) High 14.1 (10) (13) (5)* 2.56 (1)* (5) 7.69 (2) TG Normal (62) (36) (20) (20) (12) (12) Borderline high 9.86 (7) 8.51 (4) (4) (7) (8) (7) High 2.82 (2)* (7) (5) 28.2 (11) (6) (6) Very High 0 (0) 0 (0) 0 (0) 2.56 (1) 0 (0) 3.85 (1) Age groups in years: G1 (14 22), G2 (23 31), G3 (32 40), G4 (41 49), G5 (50 58), and G6 ( 59). *P<0.05, comparisons were made between the consecutive age groups (z-test for 2 population proportions). LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides. Table S7. Prevalence of various isolated and mixed dyslipidemias in the study population. Type of Dyslipidemia Percentage (proportion) At least one lipid-fraction affected 62.6 (149/238) Isolated dyslipidemia TC>200 0 (0/238) LDL-C (2/238) HDL-C < (41/238) TG (28/238) Mixed dyslipidemia TC>200, LDL-C (12/238) TC>200, HDL-C <40 0 (0/238) TC>200, TG (5/238) LDL-C 130, HDL-C < (6/238) LDL-C 130, TG (0/238) TG 150, HDL-C < (20/238) TG 150, HDL-C <40, LDL-C (3/238) HDL-C <40, LDL-C 130, TC> (12/238) HDL-C <40, TC>200, TG (1/238) TG 150, LDL-C 130, TC> (9/238) HDL-C <40, LDL-C 130, TC>200, TG (10/238) TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglyceride.
Know Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationMOLINA HEALTHCARE OF CALIFORNIA
MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationPIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia
PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,
More informationScreening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
More informationTable S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationThe Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community
International Journal of Scientific and Research Publications, Volume 4, Issue 4, April 214 1 The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community Mulugeta
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationSupplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationPlasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationHospital Authority Convention 2010 Presented by : Dr Cheng Ming Kin Medical Officer,Department of Medicine Tseung Kwan O Hospital
Hospital Authority Convention 2010 Prevalence of Cardiovascular Risk Factors, the Metabolic Syndrome and the 10-year risk for Coronary Heart Disease in the Staff of Tseung Kwan O Hospital Presented by
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationWIN QUARTERLY UTILIZATION REPORT 7/1/2010 TO 12/31/2010. EXPERTISE PARTNERSHIP V A L U E April 20, 2011
WIN QUARTERLY UTILIZATION REPORT 7/1/2010 TO 12/31/2010 EXPERTISE PARTNERSHIP V A L U E April 20, 2011 T R E N D S A N A L Y S I S S T A T I S T I C S P L A N N I N G T O O L S Participation Mass Screening
More informationCardiovascular Risk Assessment and Management Making a Difference
Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy
More informationAndrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University
CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients
More informationSection 03: Pre Exercise Evaluations and Risk Factor Assessment
Section 03: Pre Exercise Evaluations and Risk Factor Assessment ACSM Guidelines: Chapter 3 Pre Exercise Evaluations ACSM Manual: Chapter 3 Risk Factor Assessments HPHE 4450 Dr. Cheatham Purpose The extent
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationObesity Prevention and Control: Provider Education with Patient Intervention
Obesity Prevention and : Provider Education with Patient Summary Evidence Table and Population Cohen et al. (1991) 1987-1988 : RCT Location: Pittsburgh, PA Physician training session by a behavioral psychologist
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationResearch Article Comparison of Different Anthropometric Measurements and Inflammatory Biomarkers
International Inflammation Volume 2012, Article ID 124693, 5 pages doi:10.1155/2012/124693 Research Article Comparison of Different Anthropometric Measurements and Inflammatory Biomarkers Yaron Arbel,
More informationNormal cholesterol levels for men over 50
Normal cholesterol levels for men over 50 The Borg System is 100 % Normal cholesterol levels for men over 50 High cholesterol doesn't usually produce any obvious symptoms so higher than ideal cholesterol
More informationTo reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.
E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs
More informationBy: Dr Mehrnoosh Shanaki
Resveratrol could partly improve the crosstalk between canonical β-catenin/wnt and FOXO pathways in coronary artery disease patients with metabolic syndrome: A case control study By: Dr Mehrnoosh Shanaki
More informationSITA 100 mg (n = 378)
Supplementary Table 1. Summary of Sulfonylurea Background Therapy at Baseline and During the Treatment Period. Sulfonylurea at baseline, n (%) SITA 100 mg (n = 378) CANA 300 mg (n = 377) Total (N = 755)
More informationDevelopment of the Automated Diagnosis CT Screening System for Visceral Obesity
Review Asian Pacific Journal of Disease Management 2008; 2(2), 31-38 Development of the Automated Diagnosis CT Screening System for Visceral Obesity Toru Nakagawa 1), Syuichiro Yamamoto 1), Masataka Irokawa
More informationCardiovascular Disease After Spinal Cord Injury: Achieving Best Practice. Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010
Cardiovascular Disease After Spinal Cord Injury: Achieving Best Practice Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010 CAVEAT LECTOR 2 CVD-related Mortality in Aging SCI GU
More informationSupplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups
Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate
More informationPFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI.
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationClient Report Screening Program Results For: Missouri Western State University October 28, 2013
Client Report For: Missouri Western State University October 28, 2013 Executive Summary PROGRAM OVERVIEW From 1/1/2013-9/30/2013, Missouri Western State University participants participated in a screening
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationTreadmill Workstations: A Worksite Physical Activity Intervention
Treadmill Workstations: A Worksite Physical Activity Intervention Dinesh John, Ph.D. 1,2 Dixie L. Thompson, Ph.D., FACSM 1 Hollie Raynor 1, Ph.D. 1 Kenneth M. Bielak. M.D. 1 David R. Bassett, Ph.D., FACSM
More informationReplacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins
Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins Muller H, Jordal O, et al. (998) Replacement of partially hydrogenated soybean
More informationTest5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight
Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight Quest, Quest Diagnostics, the associated logo, and all associated Quest Diagnostics marks are the registered trademarks of Quest
More informationPrevalence of cardiovascular disease risk factors in people of Asian Indian origin: Age and sex variation
JCDR Original Paper Prevalence of cardiovascular disease risk factors in people of Asian Indian origin: Age and sex variation Arnab Ghosh, Minakshi Bhagat, Mithun Das 1, Sanjib Kumar Bala, Riddhi Goswami
More informationThe role of physical activity in the prevention and management of hypertension and obesity
The 1 st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Berlin, October 26-29 2005 The role of physical activity in the prevention and management of hypertension and obesity
More informationWIN UTILIZATION REPORT 7/1/2010 TO 6/30/2011
This image cannot currently be displayed. WIN UTILIZATION REPORT 7/1/2010 TO 6/30/2011 EXPERTISE PARTNERSHIP V A L U E October 18, 2011 T R E N D S A N A L Y S I S S T A T I S T I C S P L A N N I N G T
More informationSupplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±
More informationWhy Screen at 23? What can YOU do?
Why Screen at 23? Every 1 in 2 Asian American adults has diabetes or prediabetes. More than half of Asian Americans did not know they have type 2 diabetes or prediabetes. Asian Americans can develop diabetes
More informationHeart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system
LEARN Learn about HTHU Level 3 and the point system 01 IDENTIFY Identify the major risk factors for cardiovascular disease and how to improve our cardiovascular health 03 02 ACT Begin our Session 1 Goal
More informationThe Potential for High-Intensity Interval Training to Reduce Cardiometabolic Disease Risk
REVIEW ARTICLE Sports Med 2012; 42 (6): 489-509 0112-1642/12/0006-0489/$49.95/0 Adis ª 2012 Springer International Publishing AG. All rights reserved. The Potential for High-Intensity Interval Training
More informationCARDIOVASCULAR RISK FACTORS IN WHITE COLLAR WORKERS UNDER SHIFT WORK. K. Vangelova. National Center of Public Health and Analyses Sofia, Bulgaria
10.1515/AMB-2017-0011 ORIGINAL ARTICLES CARDIOVASCULAR RISK FACTORS IN WHITE COLLAR WORKERS UNDER SHIFT WORK K. Vangelova National Center of Public Health and Analyses Sofia, Bulgaria Abstract. Shift work
More informationSupplementary Online Content
Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA
More informationTerm-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY
MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationCase Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic
Case Discussions: Treatment Strategies for High Risk Populations Peter H. Jones MD, FNLA Associate Professor Methodist DeBakey Heart and Vascular Center Baylor College of Medicine Most Common Reasons for
More informationA study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital
Original Research Article A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital M. Arivumani * Assistant Professor of General Medicine, Government
More informationHigh Blood Cholesterol What you need to know
National Cholesterol Education Program High Blood Cholesterol What you need to know Why Is Cholesterol Important? Your blood cholesterol level has a lot to do with your chances of getting heart disease.
More informationCARDIOVASCULAR HEALTH
CARDIOVASCULAR HEALTH CONTROLLING YOUR RISK FACTORS Carina Price, RN, COHC Heart Disease The Facts Heart Disease Heart Disease is more common than decades in the past and often silent until it strikes.
More informationDirector, Employee Health & Productivity. Coordinator, Employee Health & Productivity
Director, Employee Health & Productivity Coordinator, Employee Health & Productivity Table 2:. ChartE: Female HDL Cholesterol Risk Levels Optimal Borderline High Risk 80% 60% 40% 20% 0% LDL Cholesterol
More information5/28/2010. Pre Test Question
Myth of Metabolic Syndrome? C. W. Spellman, DO, PhD Professor and Associate Dean Research Dir. Center Diabetes and Metabolic Disorders Department Internal Medicine, Div. Endocrinology Texas Tech University
More informationPrimary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group
Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to
More informationUnderstanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s
Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Ho Chi Minh City, Vietnam August 7, 2014 JBS 2 Risk Guidelines (2005) Based
More informationMetabolic Syndrome and Workplace Outcome
Metabolic Syndrome and Workplace Outcome Maine Worksite Wellness Initiative June 15, 2010 Alyssa B. Schultz Dee W. Edington Current Definition* of Metabolic Syndrome At least 3 of the following: Waist
More informationWhat Else Do You Need to Know? Presenter Disclosure Information. Case 1: Cardiovascular Risk Assessment in a 53-Year-Old Man. Learning Objectives
9: 1:am Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis SPEAKER Matthew Sorrentino, MD, FACC Presenter Disclosure Information The following relationships exist
More informationUpdate On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?
Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Karen Aspry, MD, MS, ABCL, FACC Assistant Clinical Professor of Medicine Warren Alpert Medical School of Brown
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationLipid Profiles. Important: Read over the section on correlation coefficients in the Guidelines for Statistics and Graphs in General Education Biology.
Biology 104 Lipid Profiles Important: Read over the section on correlation coefficients in the Guidelines for Statistics and Graphs in General Education Biology. Objectives: 1. Learn about the different
More informationDyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram
Dyslipidaemia Is there any new information? Dr. A.R.M. Saifuddin Ekram PhD,FACP,FCPS(Medicine) Professor(c.c.) & Head Department of Medicine Rajshahi Medical College Rajshahi-6000 New features of ATP III
More informationPopulation: All participants Number of Obs: Variable # Sas Name: Sas Label: Categories: Variable # Sas Name: F80VNUM. Sas Label: Categories:
Form - Last Update: 04/6/001 umber of Obs: 161771 Participant ID 1 ID Participant ID F Days since randomization/enrollment 161771-886 8-59451 516548 FDAYS F Days since randomization/enrollment F Visit
More informationNOT-FED Study New Obesity Treatment- Fasting, Exercise, Diet
NOT-FED Study New Obesity Treatment- Fasting, Exercise, Diet FASTING 16 hours a day EXCERCISE 150 min a week DIET Low carb NOSM Northern Research Conference, Kenora, 2018 R Minty, T O Driscoll, L Kelly,
More informationFrequency of Metabolic Syndrome on Diabetes Mellitus Patients in Surabaya
Biomolecular and Health Science Journal Vol 1 No 1 (2018), April 2018 ORIGINAL ARTICLE Frequency of Metabolic Syndrome on Diabetes Mellitus Patients in Surabaya Dyah Peni Puspitasari 1, Budi Widodo 2,
More informationIntegrated Health/Person Centered Health Home Austin Travis County Integral Care
Integrated Health/Person Centered Health Home Austin Travis County Integral Care Kathleen A. Casey Dawn R. Handley June 20, 2014 Influencing factors Strong track record of successful integration with FQHC
More informationTODAY S ALLIANCE MEETING
TODAY S ALLIANCE MEETING Beyond Biometrics & The Bowers + Kubota Story As told by the CEO Dexter Kubota & HIPAA Privacy and Security for Workplace Wellness Programs Laura Anderson, Esq 1 HABITS AFFECT
More informationPage 1. Disclosures. Background. No disclosures
Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen
More informationCase Study: Chris Arden. Peripheral Arterial Disease
Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she
More informationNational Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register
National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register The above graph shows a decrease in the number of patients on the
More informationIs Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea
Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Hyuncheol Bryant Kim 1, Suejin A. Lee 1, and Wilfredo Lim 2 1 Cornell University
More informationAn Overview on Cardiovascular Risks Definitions by Using Survival Analysis Techniques-Tehran Lipid and Glucose Study: 13-Year Follow-Up Outcomes
Global Journal of Health Science; Vol. 9, No. 4; 2017 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education An Overview on Cardiovascular Risks Definitions by Using Survival
More information290 Biomed Environ Sci, 2016; 29(4):
290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur
More informationCHAPTER IV RESEARCH METHOD. This study belongs to the field of Internal Medicine, specifically the field
CHAPTER IV RESEARCH METHOD 4.1 Research fields This study belongs to the field of Internal Medicine, specifically the field of Infectious and Tropical Disease. 4.2 Research location and period This study
More informationChanges and clinical significance of serum vaspin levels in patients with type 2 diabetes
Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu
More informationAssociations Between Lipid Measures and Metabolic Syndrome, Insulin Resistance and Adiponectin
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp ORIGINAL ARTICLE Epidemiology Associations Between Lipid Measures and Metabolic Syndrome, Insulin Resistance
More informationCHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION
CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions
More informationPlanned Interventions
Risk Factors Exercise Diabetes Hypertension Tobacco Use Initial Status Patient is currently exercising: More than 150 minutes Less than 150 minutes Per Week Type 1 Type 2 Borderline Diabetic :HgA1c < 6.5%;
More informationSpotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound
Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound Department of Cardiovascular Medicine Heart and Vascular Institute
More information2/11/2017. Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox. Disclosures. Carl J. Lavie, MD, FACC, FACP, FCCP
Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox Carl J. Lavie, MD, FACC, FACP, FCCP Professor of Medicine Medical Director, Cardiac Rehabilitation and Preventive Cardiology
More informationReport Operation Heart to Heart
Report Operation Heart to Heart Elkhorn Logan Valley Public Health Department (Burt, Cuming, Madison, and Stanton Counties) Gina Uhing, Health Director Ionia Research Newcastle, Nebraska Joseph Nitzke
More informationCardiovascular Disease Risk Behaviors of Nursing Students in Nursing School
International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2018, 7(8): 16-33 I J M R
More informationBODYSTAT BODY COMPOSITION AND WELLNESS PROFILE FOR. Sample Report
BODYSTAT BODY COMPOSITION AND WELLNESS PROFILE FOR Sample Report Copyright 1998, 22. Bodystat (Isle of Man) Ltd. BODYSTAT and the BODYSTAT LOGO are the internationally registered trade marks of BODYSTAT
More informationGlycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men:
Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study Jaakko Mursu, Jyrki K. Virtanen, Tiina H. Rissanen,
More informationIntroduction to results on Seasonal Changes in Cholesterol
Introduction to results on Seasonal Changes in Cholesterol Ed Stanek - May 2001 Introduction This report summarizes results relative to seasonal changes in cholesterol, and provides alternative results
More informationSmall dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study
Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Hidenori Arai 1, Yoshihiro Kokubo 2, Makoto Watanabe 2, Tatsuya Sawamura 3, Tomonori
More informationHealthy Firefighters USA Program
Healthy Firefighters USA Program www.healthyfirefightersusa.org Corporate: Bob Antonacci MSEd Exercise Physiologist bob@healthyfirefightersusa.org Satellite: Chris Krogedal BS Exercise Physiologist chris@healthyfirefightersusa.org
More informationPositive Change for Life
Positive Change for Life Dr Sharon Avery, Project lead on behalf of the Alfred Late Effects Clinic, on behalf of the Alfred Late Effects Clinic, Leukaemia Foundation and Southern Melbourne Integrated Cancer
More informationRisk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication
41 Research Article Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication Amarjeet Singh*, Sudeep bhardwaj, Ashutosh aggarwal Department of Pharmacology, Seth
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationEFFICIENCY AND COST-EFFECTIVENESS OF DYSLIPIDEMIA SCREENING METHODS AMONG WORKERS IN BANGKOK
EFFICIENCY AND COST-EFFECTIVENESS OF DYSLIPIDEMIA SCREENING METHODS AMONG WORKERS IN BANGKOK Unchalee Sanguantrakul, Wiroj Jiamjarasrangsi and Thosporn Vimolket 1 Department of Preventive and Social Medicine,
More information2013 Hypertension Measure Group Patient Visit Form
Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part
More informationSupplementary Online Content
Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More information